tiltan pharma logo icon of a house icon of an envelope
image of tiltan pharma logo
image of a scientist working  in a lab
image of medicine bottles
image of glassaes and pen laid on paper

About us

is an Israeli biopharmaceutical company, established in 2006, that developed a proprietary anti-angiogenic and immune modulatory platform technology...

Tiltan's drug combination

Tiltan has developed a proprietary combinatorial drug therapy  that consists of metronomic chemotherapy together with...

Clinical trials

Tiltan Pharma started its first human trial with its investigational product (IP), phase 1/2, on November 2006 in Sheba Medical Center, Israel. The main objective...

Scientific publications

TL-118—anti-angiogenic treatment in pancreatic cancer: a case report.


Built by Badboy.co.il  © copyright 2015